“As the Pfizer-BioNTech vaccine begins to make its entry into the supply chain, optimism by public health officials regarding making significant progress in combating the pandemic’s impact was boosted by the news Wednesday that the FDA has already telegraphed quick emergency use authorization of the second coronavirus vaccine made by biotechnology company Moderna.

The question on the minds of most Californians is how a vaccination program will work once the initial vaccines have been used to inoculate the state’s front-line healthcare workers and residents at the highest risk of contracting and dying from the coronavirus…”

[Read the full article]